Galanin antagonist

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530326, 530325, C07K 500, C07K 700, C07K 1700, A61K 3800

Patent

active

055762964

ABSTRACT:
A galanin antagonist which is a galanin receptor ligand is described. New peptides, Galanin (1-12)-Pro-Substance P(5-11), Galanin (1-12)-Pro-Bradykinin(2-9), Galanin (1-12)-Pro-Pro-Pro- (Leu.sup.5 -Enkephalin (5-1), Galanin (1-12)-Pro-Lys(.epsilon.-NH-)Pro-(Leu5-Enkephalin (5-1) and functional analogues and functional derivatives thereof are disclosed. The peptides are used in pharmaceutical preparations to treat a disorder in a mammal which depends on the physiological function of galanin at the galanin receptor.

REFERENCES:
Fisone, et al., Proc. Natl. Acad. Sci. USA, vol. 86, pp. 9588-9591 (1989).
Lagny-Pourmir, et al., Peptides, vol. 10, pp. 757-761 (1989).
Hermansen, et al, Acta Endocr. (Copenh) 121:545-550 (1989).
Dunning, et al., Diabetes, vol. 37, pp. 1157-1162 (1988).
Lindskog, et al., European Journal of Pharmacology, 210, pp. 183-188 (1992).
Wiesenfeld-Hallin, et al., Proc. Natl. Acad. Sci. USA, vol. 89, pp. 3334-3337 (1992).
Bartfai, et al., Proc. Natl. Acad. Sci. USA, vol. 88, pp. 10961-10965 (1991).
Cecil Textbok of Medicine, 1992 pp. 2076-2077.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Galanin antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Galanin antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galanin antagonist will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-541056

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.